State Of Wyoming Bristol Myers Squibb CO Transaction History

State Of Wyoming

$592 Million
Q2 2024

A detailed history of State Of Wyoming transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Wyoming holds 5,211 shares of BMY stock, worth $269,669. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,211

Previous 1,926 170.56%

Holding current value

$269,669

Previous $104,000 107.69%

% of portfolio

0.04%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $132,221 - $174,072	3,285 Added 170.56%	5,211 $216,000
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $141,876 - $160,860	-2,957 Reduced 60.56%	1,926 $104,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $121,684 - $145,203	2,510 Added 105.77%	4,883 $250,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $84,635 - $94,635	-1,462 Reduced 38.12%	2,373 $137,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $261,784 - $290,670	-4,109 Reduced 51.72%	3,835 $245,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $11,893 - $13,489	-181 Reduced 2.23%	7,944 $550,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $147,437 - $174,586	2,153 Added 36.05%	8,125 $584,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $480 - $284,000	3,696 Added 162.39%	5,972 $424,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $1,379 - $1,519	-19 Reduced 0.83%	2,276 $175,000
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $58,406 - $70,034	-950 Reduced 29.28%	2,295 $168,000
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $48,374 - $56,393	902 Added 38.5%	3,245 $202,000
Q3 2021 Feb 14, 2022	BUY	$59.17 - $69.31 $138,635 - $162,393	2,343 New	2,343 $139,000
Q3 2021 Feb 11, 2022	SELL	$59.17 - $69.31 $141,238 - $165,442	-2,387 Closed	0 $0
Q2 2021 Feb 14, 2022	BUY	$61.91 - $67.42 $147,779 - $160,931	2,387 New	2,387 $159,000

Others Institutions Holding BMY

# of Institutions

2,402

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account